Letter Regarding Article by Devereux Et Al, "Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial"
Circulation - United States
doi 10.1161/circulationaha.104.525519
Full Text
Open PDFAbstract
Available in full text
Date
June 7, 2005
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)